1177:HKG
Sino Biopharmaceutical Ltd
HK$5.25
arrow_downward
-0.38%(-0.020) 1D
Oct 16, 4:08:14 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1177...
Open
HK$5.40
High
HK$5.50
Low
HK$5.14
Mkt. cap
98.09B
Avg. vol.
69.33M
Volume
83.88M
Dividend
2.29%
Quarterly dividend
HK$0.03
Ex-dividend date
Aug 29, 2025
P/E ratio
33.86
52-wk high
HK$7.79
52-wk low
HK$4.19
EPS
HK$0.16
Shares outstanding
12.64B
No. of employees
23K
Open
HK$5.40
High
HK$5.50
Low
HK$5.14
Mkt. cap
98.09B
Avg. vol.
69.33M
Volume
83.88M
Dividend
2.29%
Quarterly dividend
HK$0.03
Ex-dividend date
Aug 29, 2025
P/E ratio
33.86
52-wk high
HK$7.79
52-wk low
HK$4.19
EPS
HK$0.16
Shares outstanding
12.64B
No. of employees
23K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Sino Biopharm reports 10.60 percent growth for Sino Biopharm stock
Profile
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd